Table 1.
Laboratory data on admission
| WBC | 4.1×109/L | PT-INR | 0.99 |
| RBC | 4.33×1012/L | APTT | 29.6 s |
| Hb | 125g/L | IgG | 746 mg/dL |
| Ht | 36.10% | IgM | 75 mg/dL |
| Plt | 187×109/L | IgA | 147 mg/dL |
| AST | 147 IU/L | IgG4 | 19.4 mg/dL |
| ALT | 406 IU/L | ANA | 1:80 |
| LDH | 246 IU/L | ASMA | <20 |
| T-Bil | 1.1 mg/dL | AMA | <20 |
| ALP | 1330 IU/ L | anti-M2 | <1.5 |
| GGT | 1290 IU/L | HBsAg | (-) |
| Amylase | 1034 IU/L | anti-HCV Ab | (-) |
| Lipase | 860 IU/L | CEA | 1.5 ng/mL |
| Trypsin | 11800 ng/mL | CA19-9 | 43.7 IU/mL |
| TP | 5.8 g/dL | ||
| Alb | 3.3 g/dL | ||
| CRP | 10.77 mg/dL | ||
| UN | 11.3 mg/dL | ||
| Cre | 1.00 mg/dL | ||
| Na | 130 mEq/L | ||
| K | 4.3 mEq/L | ||
| Cl | 97 mEq/L |
anti-HCV Ab, anti-hepatitis C virus antibody; Alb, albumin; ALP, alkaline phosphatase; ALT, alanine aminotransferase; AMA, anti-mitochondrial antibodies; ANA, antinuclear antibodies; APTT, activated partial thromboplastin time; ASMA, anti-smooth muscle antibody; AST, aspartate aminotransferase; CA19-9, cancer antigen 19–9; CEA, carcinoembryonic antigen; Cre, creatinine; CRP, C reactive protein; GGT, γ-gamma-glutamyl transpeptidase; Hb, haemoglobin; HBsAg, hepatitis B surface antigen; Ht, hematocrit; LDH, lactate dehydrogenase; Plt, platelet count; PT-INR, prothrombin time and international normalized ratio; RBC, red blood cells; T-bil, total bilirubin; TP, total protein; UN, urea nitrogen; WBC, white blood cells.